RIL
NRIX icon

Rothschild Investment LLC’s Nurix Therapeutics NRIX Stock Holding History

Rothschild Investment LLC’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.87K Buy
283
+214
+310% +$3.65K ﹤0.01% 2099
2026
Q1 		$1.07K Buy
69
+20
+41% +$332 ﹤0.01% 2836
2025
Q4 		$930 Buy
+49
New +$704 ﹤0.01% 2705
2025
Q3 		– Sell
-195
Closed -$2.22K – 3214
2025
Q2 		$2.22K Buy
195
+35
+22% +$378 ﹤0.01% 2002
2025
Q1 		$1.9K Buy
160
+110
+220% +$1.84K ﹤0.01% 1929
2024
Q4 		$942 Sell
50
-10
-17% -$229 ﹤0.01% 2249
2024
Q3 		$1.35K Buy
60
+30
+100% +$680 ﹤0.01% 1954
2024
Q2 		$626 Buy
30
+20
+200% +$311 ﹤0.01% 1880
2024
Q1 		$147 Buy
+10
New +$108 ﹤0.01% 1925

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WFA
WestHill Financial Advisors San Rafael, California $587M AUM 20.13% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Rothschild Investment LLC's NRIX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Nurix Therapeutics (NRIX) stake by 310% in Q2 2026, buying an estimated $3.65K and bringing the position to 283 shares worth $6.87K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Rothschild Investment LLC first reported a position in NRIX in Q1 2024 and has held it in 9 quarters since. 64 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Rothschild Investment LLC held 283 shares of Nurix Therapeutics worth $6.87K as of Q2 2026.
  • Rothschild Investment LLC bought 214 Nurix Therapeutics shares in Q2 2026, an estimated $3.65K.
  • Nurix Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2099 holding.
  • Rothschild Investment LLC first reported a position in Nurix Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 64 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.